UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM 8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date of
Report (Date of earliest reported): November 2, 2009
Midas
Medici Group Holdings, Inc.
(Exact
name of registrant as specified in its charter)
Delaware | 000-52621 | 37-1532843 |
(State or other jurisdiction of incorporation) | Commission file number | (IRS Employer Identification No.) |
445 Park
Avenue, 20th
Floor, New York, New York 10222
Registrant’s
telephone number, including area code (212)
792-0921
Copies
to:
Thomas
Rose, Esq.
Marcelle
S. Balcombe, Esq.
Sichenzia
Ross Friedman Ference LLP
61
Broadway, 32 nd
Floor
New York,
New York 10006
Phone:
(212) 930-9700
Fax:
(212) 930-9725
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
/_/
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
/_/
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
/_/
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
(17 CFR 240.14d-2(b))
/_/
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
(17 CFR 240.13e-4(c))
On
November 2, 2009, Frank Henson was appointed as a Director of Midas Medici Group
Holdings, Inc. (the “Company”). Mr. Henson is a Managing Director in
the Institutional Sales Group at Cohen & Company Securities LLC, an
institutional broker-dealer focused on debt securities. Prior to joining Cohen
& Company Securities LLC, Mr. Henson held a position of Managing Director in
the Corporate Bond Research Department at Bear Stearns, where he covered retail
and consumer product companies from 2005 to 2008. In 2006 and 2007, Mr. Henson
was recognized by Institutional Investor for his research on retail
companies. Prior to working at Bear Stearns, Mr. Henson worked at
Morgan Stanley with roles in the Corporate Bond Research and Investment Banking
Departments. From 2001 to 2005, Mr. Henson worked in Morgan Stanley’s Corporate
Bond Research Department, covering retail and consumer product companies and
from 1995 to 1998, Mr. Henson worked in Morgan Stanley’s Investment Banking
Department, implementing numerous initial and secondary public equity offerings
in New York, as well as M&A transactions in Southeast Asia.
Mr.
Henson holds an MBA from Columbia Business School and a Bachelor of Arts Degree
from Rutgers College.
Also, on
November 2, 2009, Johnson Kachidza was appointed as Chief Financial Officer of
the Company. Mr. Kachidza currently serves as President and Co-Executive
Chairman of the Company. Since 2002, Mr. Kachidza has been a Managing Principal
and Co-Founder of Knox Lawrence International, LLC (“KLI”), an energy services
investment company that has completed over $600 million in acquisitions to date.
He is currently Executive Chairman of Dearborn Midwest Conveyor Co., Inc., a
provider of pollution control systems to the power and automotive industries.
During his tenure at KLI, Mr. Kachidza co-founded Consonus Technologies, Inc. in
2005 and has led acquisitions, integrations, and held operating positions,
including Executive Chairman, President, and CEO for different energy services
companies. Mr. Kachidza currently serves as a board member of Consonus
Technologies, Utilipoint International and Transactis, Inc. He is also on the
Board of Directors of Shared Interest, a non-profit organization focused on
micro-lending.
From 1997
to 2001, Mr. Kachidza was an investment banker at Merrill Lynch and JP Morgan
Chase, where he was directly involved in billions of dollars of M&A and debt
and equity financing transactions in the energy sector. Mr. Kachidza began his
career as a project engineer at General Electric from 1991 to 1995 and holds US
patent #5686795 for an innovative fluorescent lamp design. Mr. Kachidza received
his MBA from University of Chicago Booth School of Business, a Master of Science
in Materials Engineering from University of Illinois at Urbana-Champaign and a
Bachelor of Arts Degree in Chemistry from Knox College.
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Midas Medici Group Holdings, Inc. | |||
Date:
November 6, 2009
|
By:
|
/s/ Nana Baffour | |
Nana
Baffour, CEO and
Co-Executive
Chairman
|
|||
3